Cardiovascular Pharmacogenomics: Current Status and Future Directions—Report of a National Heart, Lung, and Blood Institute Working Group

Kiran Musunuru, Dan M. Roden, Robin Boineau, Michael R. Bristow, Timothy A. McCaffrey, Christopher Newton‐Cheh, Dina N. Paltoo, Yves Rosenberg, Jay G. Wohlgemuth, Issam Zineh, Ahmed A. K. Hasan
2012 Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease  
ton University. The conference brought together leaders from academia, industry, and government to (1) discuss personalized medicine's current and potential impact on cardiovascular patient outcomes; (2) review emerging technologies and applications that may shape the field in the future; (3) discuss the results of an American College of Cardiology survey examining personalized medicine adoption rates among US cardiologists; (4) identify the barriers to adoption of pharmacogenetics-based
more » ... lized medicine in cardiovascular practice; and (5) develop recommendations for next steps with an emphasis on actions and evidence generation that are needed for adoption and improved quality of cardiovascular patient care.
doi:10.1161/jaha.111.000554 pmid:23130127 pmcid:PMC3487365 fatcat:b67sxx5ryvbtzbum6wsxyg3k5e